Douglas N. Gurevitch, Timothy R. Walker, Michael J. Kealy, Nance L. Hall, Andy R. Watson
Sequana Therapeutics is engaged in identifying the genes responsible for common diseases such as asthma, diabetes, osteoporosis, and others. The company has developed discovery technology based on positional cloning, a method that uses statistical analysis of disease inheritance patterns to isolate disease genes. Sequana's approach involves five distinct stages: DNA collection; genetic mapping (genotyping); physical mapping; DNA sequencing and mutation analysis; and gene characterization and assay development. Sequana at this time has several Packard MultiProbe robots that are used in these processes (see figures 1 and 2). We have found these robots robust, reliable and easy to program.
Back to Resume
Back to Home
Updated 2/4/2009